Interestingly, p53-null cells exposed to oxaliplatin exhibited a Bax down-regulation, associating with little cytotoxicity; such a phenomena is also correlated with colorectal carcinogenesis and drug resistance as reported elsewhere [25]. The gene discussed is TP53; the disease is medical procedure.